MANUFACTURING SERVICES AGREEMENTManufacturing Services Agreement • March 15th, 2023 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
This MANUFACTURING SERVICES AGREEMENT (this “Agreement”) is made as of December 31 2022 (“Execution Date”) and effective as of January 1, 2023 ("Effective Date").
FIRST AMENDMENT TO MANUFACTURING SERVICES AGREEMENTManufacturing Services Agreement • March 15th, 2023 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances)
THIS FIRST AMENDMENT to the MANUFACTURING SERVICES AGREEMENT (“First Amendment”) is made and entered into on this 6th day of March 2023 (“First Amendment Effective Date”), by and between ACORDA THERAPEUTICS, INC. (“Acorda”), a Delaware corporation, and CATALENT MASSACHUSETTS, LLC (“Manufacturer”), a Delaware limited liability company.
SETTLEMENT AND RELEASE AGREEMENTSettlement Agreement • March 15th, 2023 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
This Settlement and Release Agreement (the “Settlement Agreement”) is made as of 31st day of December, 2022 (“Execution Date and effective as of 31st day of December 2022 (the “Settlement Effective Date”), by and between Acorda Therapeutics, Inc., a corporation, with a place of business at 2 Blue Hill Plaza, 3rd Floor, Pearl River, New York 10965, USA (“Acorda”), and Catalent Massachusetts LLC, a Delaware limited liability company, with a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873, USA (“Catalent”).
September 30, 2010Manufacturing Services Agreement • March 15th, 2023 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
THIS AGREEMENT WITNESSES that in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
